Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2547-2549

  Sevinç, Akin ^a   Yannoukakos, Drakoulis ^b   Konstantopoulou, Irene ^b   Manguoglu, Esra ^c   Lüleci, Güven ^c   Çolak, Taner ^c   Akyerli, Cemaliye ^a   Çolakoglu, Gülsen ^a   Tez, Mesut ^d   Sayek, Iskender ^e   Gerassimos, Voutsinas ^b   Nasioulas, George ^b   Papadopoulou, Eirene ^f   Florentin, Lina ^g   Kontogianni, Elena ^h   Bozkurt, Betül ⁱ   Kocabas, Neslihan Aygün ^j   Karakaya, Ali Esat ^j   Yulug, Isik G ^a   Özçelik, Tayfun ^a,k  

^a BILKENT UNIVERSITY   (Turkey)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c AKDENIZ UNIVERSITY   (Turkey)

^d Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

^e HACETTEPE UNIVERSITY   (Turkey)

^f HYGEIA HOSPITAL   (Greece)

^g Alfalab Molecular Biology and Cytogenetics Center   (Greece)

^h IVF and Genetics   (Greece)

ⁱ ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^j GAZI UNIVERSITY   (Turkey)

^k Ayhan Sahenk Foundation   (Turkey)

more..

Author keywords

Breast cancer; RNASEL

Indexed keywords

ARGININE; GLUTAMINE; RIBONUCLEASE L;

ADOLESCENT; AGED; AMINO ACID SEQUENCE; AMPLIFICATION REFRACTORY MUTATION SYSTEM; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; GREECE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN VARIANT; RISK FACTOR; TURKEY (REPUBLIC);

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA, NEOPLASM; ENDORIBONUCLEASES; FEMALE; HUMANS; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 4444304450     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Silverman RH: Implications for RNase L in prostate cancer biology. Biochem 42: 1805-1812, 2003.
2. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH and Witte JS: RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nature Genet 32: 581-583, 2002.
3. Nakazato H, Suzuki K, Matsui H, Ohtake N, Nakata S and Yamanaka H: Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br J Cancer 89: 691-696, 2003.
4. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P et al: Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nature Genet 30: 181-184, 2002.
5. Squire J, Zhou A, Hassel BA, Nie H and Silverman RH: Localization of the interferon-induced, 2-5A-dependent RNase gene (RNS4) to human chromosome 1q25. Genomics 19: 174-175, 1994.
6. Chen LC, Dollbaum C and Smith HS: Loss of heterozygosity on chromosome lq in human breast cancer. Proc Natl Acad Sci USA 86: 7204-7207, 1989.
7. Balmain A and Ponder B: The genetics and genomics of cancer. Nature Genet 33: 238-244, 2003.
8. Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnel SK, Qian C, Marks AF, Slager SL, Peterson BJ, Smith DI, Cheville JC et al: Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 72: 270-280, 2003.